Kamada (KMDA) Deferred Taxes (2012 - 2026)
Kamada (KMDA) posted quarterly Deferred Taxes of $119000.0 for Q1 2026, up 26.6% year-on-year from $94000.0 in Q1 2025, and down 17.36% on a QoQ basis from $144000.0 in Q4 2025.
Kamada (KMDA) Deferred Taxes (2012 - 2026) Analysis & Trends
Kamada (KMDA) has reported Deferred Taxes for 15 consecutive years, with $119000.0 the latest figure, recorded in Q1 2026.
- Quarterly Deferred Taxes rose 26.6% year-over-year to $119000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $476000.0 (up 3.93% YoY) and the FY2025 annual result came in at $475000.0, changed 0.21% from the prior year.
- Deferred Taxes fell to $119000.0 in Q1 2026 per KMDA's latest filing, from $144000.0 in the prior quarter.
- Over the last five years, Deferred Taxes for KMDA reached as high as $144000.0 in Q4 2025 and fell as low as -$512000.0 in Q2 2023.
- A 5-year average of -$20015.7 and a median of $48777.0 in 2023 frame the typical range for Deferred Taxes.
- Annual changes were most pronounced in 2023 — Deferred Taxes sank 13110.23% — and 2024, when it surged 274409.8%.
- Year by year, Deferred Taxes stood at $1256.0 in 2022, then slumped by 95.94% to $51.0 in 2023, then jumped by 274409.8% to $140000.0 in 2024, then gained by 2.86% to $144000.0 in 2025, then decreased by 17.36% to $119000.0 in 2026.
- According to Business Quant data, Deferred Taxes over the past three periods registered $119000.0, $144000.0, and $119000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -22.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 34.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 25.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -69.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -61.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Kamada | 401.22 Mn | 328.07 Mn | 19.12 Mn | 119,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,000.00 |
| Dec 31, 2025 | 144,000.00 |
| Sep 30, 2025 | 119,000.00 |
| Mar 31, 2025 | 94,000.00 |
| Dec 31, 2024 | 140,000.00 |
| Sep 30, 2024 | 97,000.00 |
| Jun 30, 2024 | 127,000.00 |
| Mar 31, 2024 | 112,000.00 |
| Dec 31, 2023 | 51.00 |
| Sep 30, 2023 | -279,000.00 |
| Jun 30, 2023 | -512,000.00 |
| Mar 31, 2023 | 3,554.00 |
| Dec 31, 2022 | 1,256.00 |
| Sep 30, 2022 | -2,112.00 |
| Jun 30, 2022 | -374,000.00 |
| Mar 31, 2022 | -110,000.00 |
| Dec 31, 2021 | -2,124.00 |
| Sep 30, 2021 | -2.40 Mn |
| Jun 30, 2021 | -1.21 Mn |
| Mar 31, 2021 | -1.15 Mn |